Literature DB >> 8092217

Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus.

S A AbdRabbo1.   

Abstract

OBJECTIVE: The objective of this study was to test the efficacy of a novel stepwise technique of uterine devascularization for management of uncontrollable postpartum hemorrhage. STUDY
DESIGN: Stepwise uterine devascularization was performed for 103 patients to control intractable postpartum hemorrhage not responding to classic management. This technique entails five successive steps, so if bleeding is not controlled by one step the next step is taken until bleeding stops. The steps were (1) unilateral uterine vessel ligation, (2) bilateral uterine vessel ligation, (3) low uterine vessel ligation, (4) unilateral ovarian vessel ligation and (5) bilateral ovarian vessel ligation.
RESULTS: The procedure was effective in all cases (100%), and hysterectomy was not needed in any case. No complications occurred, and the survival rate was 100%. Among the patients followed up normal menstruation and pregnancy occurred.
CONCLUSION: Stepwise uterine devascularization is an effective and safe alternative to hysterectomy for management of uncontrollable postpartum hemorrhage.

Entities:  

Mesh:

Year:  1994        PMID: 8092217     DOI: 10.1016/0002-9378(94)90084-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

1.  B-lynch: a technique for uterine conservation or deformation? A case report with literature review.

Authors:  Jasmina Begum; P Pallave; Seetesh Ghose
Journal:  J Clin Diagn Res       Date:  2014-04-15

Review 2.  Development of Asherman syndrome after conservative surgical management of intractable postpartum hemorrhage.

Authors:  Ciaran A Goojha; Allison Case; Roger Pierson
Journal:  Fertil Steril       Date:  2010-03-26       Impact factor: 7.329

3.  Cervical tourniquet in case of uncontrollable haemorrhage during caesarean section owing to a placenta accreta.

Authors:  Q C A Huijgen; A F Gijsen; E Hink; P J M Van Kesteren
Journal:  BMJ Case Rep       Date:  2013-04-22

4.  Fertility and pregnancy outcomes following conservative treatment for placenta accreta.

Authors:  Loïc Sentilhes; Gilles Kayem; Clémence Ambroselli; Magali Provansal; Hervé Fernandez; Franck Perrotin; Norbert Winer; Fabrice Pierre; Alexandra Benachi; Michel Dreyfus; Estelle Bauville; Dominique Mahieu-Caputo; Loïc Marpeau; Philippe Descamps; Florence Bretelle; François Goffinet
Journal:  Hum Reprod       Date:  2010-09-10       Impact factor: 6.918

5.  Persistent postpartum haemorrhage after failed arterial ligation: value of pelvic embolisation.

Authors:  Yann Fargeaudou; Olivier Morel; Philippe Soyer; Etienne Gayat; Marc Sirol; Mourad Boudiaf; Henri Dahan; Emmanuel Barranger; Alexandre Mebazaa; Olivier le Dref
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

6.  Transcatheter arterial embolotherapy: a therapeutic alternative in obstetrics and gynecologic emergencies.

Authors:  Carol C Wu; Margaret H Lee
Journal:  Semin Intervent Radiol       Date:  2006-09       Impact factor: 1.513

7.  Transarterial embolization for the treatment of massive bleeding in gynecologic and obstetric emergencies: a single center experience.

Authors:  Keerati Hongsakul; Apiradee Songjamrat; Sorracha Rookkapan
Journal:  Emerg Radiol       Date:  2014-02-13

Review 8.  Treatment for primary postpartum haemorrhage.

Authors:  Hatem A Mousa; Jennifer Blum; Ghada Abou El Senoun; Haleema Shakur; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2014-02-13

9.  Emergencies associated with pregnancy and delivery: peripartum hemorrhage.

Authors:  Franz Kainer; Uwe Hasbargen
Journal:  Dtsch Arztebl Int       Date:  2008-09-12       Impact factor: 5.594

10.  Efficacy of selective arterial embolisation for the treatment of life-threatening post-partum haemorrhage in a large population.

Authors:  Cyril Touboul; Wassim Badiou; Julien Saada; Jean-Pierre Pelage; Didier Payen; Eric Vicaut; Denis Jacob; Arash Rafii
Journal:  PLoS One       Date:  2008-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.